Q4 2024 Management View CEO Jennifer Ernst highlighted significant advancements, including the acquisition of exclusive worldwide rights to the Phase III immunomodulatory drug candidate Entolimod, ...

The Balochistan Liberation Army has long been a shadowy force on Pakistan’s security landscape, transforming from a ...

The Baloch Yakjehti Committee (BYC), an organisation led by the controversial Baloch rights activist Mahrang Baloch, has come ...

Researchers in Portugal have simulated 800 power purchase agreemeents across eight different contract type and have found ...

Hundreds of train passengers taken hostage by a militant group in Pakistan were freed in mid-March after a 30-hour siege, ...

After separatists in the southwestern Pakistani province of Balochistan claimed responsibility for a deadly bombing in the ...

TECELRA® launch momentum accelerating – 10 patients apheresed in Q1 2025 and 3 in 2024; 20 ATCs available; all manufacturing and supply goals ...

The Balochistan Liberation Army (BLA) is eyeing the nuclear weapons of Pakistan after giving a jolt by hijacking the Jaffar Express which claimed several lives in the incident. The Pakistan Army and ...

The FDA has accepted the resubmitted BLA for linvoseltamab for patients with relapsed/refractory multiple myeloma.

FDA accepts Capricor's Biologics License Application for priority review, advancing deramiocel for DMD cardiomyopathy.

After two days of intense military operations, 33 attackers were killed, and 26 passengers — including 18 army and FC ...

INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...